Real life safety, effectiveness and quality of life of trastuzumab deruxtecan in patients with metastatic or unresectable HER2-positive breast cancer: a French ambispective multicentre 2 year-follow-up cohort study First published 09/12/2024 Last updated 09/12/2024 EU PAS number:EUPAS1000000341 Study Ongoing